HER2 breast cancer biomarker detection using a sandwich optical fiber assay

被引:100
|
作者
Loyez, Mederic [1 ]
Lobry, Maxime [2 ]
Hassan, Eman M. [3 ,4 ]
DeRosa, Maria C. [3 ]
Caucheteur, Christophe [2 ]
Wattiez, Ruddy [1 ]
机构
[1] Univ Mons, Prote & Microbiol Dept, Pl Parc 20, B-7000 Mons, Belgium
[2] Univ Mons, Electromagnetism & Telecommun Dept, Bld Dolez 31, B-7000 Mons, Belgium
[3] Carleton Univ, Inst Biochem, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada
[4] Natl Res Council Canada, Metrol Res Ctr, Ottawa, ON K1A 0R6, Canada
关键词
Optical fiber; Breast cancer diagnosis; HER2; Biomarker; Aptamers; Surface plasmon resonance; FILM THICKNESS; SENSITIVITY; SPR; MULTIMODE; GRATINGS; DESIGN; SENSOR;
D O I
10.1016/j.talanta.2020.121452
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Optical fiber-based surface plasmon resonance (OF-SPR) sensors have demonstrated high versatility and performances over the last years, which propelled the technique to the heart of numerous and original biosensing concepts. In this work, we contribute to this effort and present our recent findings about the detection of breast cancer HER2 biomarkers through OF-SPR optrodes. 1 cm-long sections of 400 mu m core-diameter optical fibers were covered with a sputtered gold film, yielding enhanced sensitivity to surface refractive index changes. Studying the impacts of the gold film thickness on the plasmonic spectral response, we improved the quality and reproducibility of the sensors. These achievements were correlated in two ways, using both the central wavelengths of the plasmon resonance and its influence on the bulk refractive index sensitivity. Our dataset was fed by additional biosensing experiments with a direct and indirect approach, relying on aptamers and antibodies specifically implemented in a sandwich layout. HER2 biomarkers were specifically detected at 0.6 mu g/mL (5.16 nM) in label-free while the amplification with HER2-antibodies provided a nearly hundredfold signal magnification, reaching 9.3 ng/mL (77.4 pM). We believe that these results harbinger the way for their further use in biomedical samples.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] HER2 assessment in breast cancer
    Sapino, Anna
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S30 - S31
  • [22] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [23] HER2 heterogeneity in breast cancer
    Sala, Elena
    Saccheri, Fabiana
    Crosti, Francesca
    Villa, Nicoletta
    Gautiero, Eugenio
    Brenna, Ambrogio
    Dalpra, Leda
    CHROMOSOME RESEARCH, 2013, 21 : S112 - S112
  • [24] Gene-protein assay for assessing breast cancer HER2 status
    Tot, T.
    Nitta, H.
    Akiyama, F.
    Horii, R.
    Tsuda, H.
    Masuda, S.
    Nielsen, S.
    Sotiriou, C.
    Reis-Filho, J.
    Chenard, M. -P.
    Viale, G.
    Sapino, A.
    VIRCHOWS ARCHIV, 2016, 469 : S49 - S49
  • [25] Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer
    Ohara, Ako
    Naoi, Yasuto
    Shimoda, Masafumi
    Tanei, Tomonori
    Kagara, Naofumi
    Miyake, Tomohiro
    Sota, Yoshiaki
    Kim, Seung Jin
    Shimazu, Kenzo
    Noguchi, Shinzaburo
    BREAST CANCER, 2021, 28 (04) : 977 - 982
  • [26] Optical imaging of metabolism in HER2 overexpressing breast cancer cells
    Walsh, Alex
    Cook, Rebecca S.
    Rexer, Brent
    Arteaga, Carlos L.
    Skala, Melissa C.
    BIOMEDICAL OPTICS EXPRESS, 2012, 3 (01): : 75 - 85
  • [27] Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer
    Ako Ohara
    Yasuto Naoi
    Masafumi Shimoda
    Tomonori Tanei
    Naofumi Kagara
    Tomohiro Miyake
    Yoshiaki Sota
    Seung Jin Kim
    Kenzo Shimazu
    Shinzaburo Noguchi
    Breast Cancer, 2021, 28 : 977 - 982
  • [28] Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine Therapy
    Huang, Wei
    Tyburski, Haley
    Finkelman, Brian
    Turner, Bradley
    Weiss, Anna
    Dhakal, Ajay
    Skinner, Kristin
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2024, 104 (03) : S175 - S176
  • [29] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [30] HER2 low testing in breast cancer: How to optimize detection
    Cecchi, F.
    Carrolle, D.
    Gustavson, M.
    Sridhar, S.
    de los Reyes, M.
    Thyparambil, S.
    Bhalkikar, A.
    Liao, W-L.
    Coats, S.
    Hembrough, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S21 - S21